Hence, one of the potential improvements in the production of therapeutic T cells would be to reassess the role of IL-2 in the generation of T cells that are efficient in killing tumor cells and that will persist as memory cells once transferred in vivo. This evidence concerns the gene IL2 and neoplasm.